Vanda Pharmaceuticals
VNDA
#7136
Rank
NZ$0.85 B
Marketcap
NZ$14.54
Share price
1.22%
Change (1 day)
75.99%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$67.93 Million a decrease over its 2023 earnings that were of -NZ$23.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion205.85%
2024 -NZ$67.93 Million191.43%
2023 -NZ$23.31 Million-320.45%
2022 NZ$10.57 M-84.99%
2021 NZ$70.44 M54.8%
2020 NZ$45.5 M19.42%
2019 NZ$38.1 M4.93%
2018 NZ$36.31 M-228.6%
2017 -NZ$28.24 Million-8.98%
2016 -NZ$31.03 Million-53.79%
2015 -NZ$67.14 Million-30.18%
2014 -NZ$96.16 Million173.08%
2013 -NZ$35.21 Million-25.33%
2012 -NZ$47.16 Million163.61%
2011 -NZ$17.89 Million-221.15%
2010 NZ$14.76 M-124.53%
2009 -NZ$60.2 Million-29.44%
2008 -NZ$85.31 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.11 Billion170.55%
2005 -NZ$40.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.12 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.31 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.79 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.59 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.57 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.41 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.69 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA